From Azerbaijan’s troubling human rights record to its contested actions in Nagorno-Karabakh, the country’s motivations deserve scrutiny. Is this pivot towards sustainability a genuine effort or a strategic play to bolster its international image?
Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.